retatrutide lancet Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA Retatrutide Delivers Significant Hemoglobin A1C

They are not approved for human or animal use and are not intended for diagnosis, treatment, or clinical application

By reducing your appetite, the drugs help you eat less and lose weight but their effects only last as long as you take them

S2CID 2141649

This article explains why plateaus happen, what the clinical data actually says, and five practical steps you can take to break through

The company publishes available lab reports for its listed products and updates documentation as new batch information becomes available

While GLP-1s stay in your system for weeks, injecting high doses (2.4mg of Wegovy or 15mg Mounjaro, for example) may cause serious adverse effects